Search Results - Angelo Delmonte

  • Showing 1 - 17 results of 17
Refine Results
  1. 1

    How to discriminate non-small cell lung cancer (NSCLC) cases from an Italian administrative database? A retrospective, secondary data use study for evaluating a novel algorithm per... by Ilaria Massa, William Balzi, Andrea Roncadori, Valentina Danesi, Silvia Manunta, Nicola Gentili, Angelo Delmonte, Lucio Crinò, Mattia Altini

    Published in BMJ Open (2021-09-01)
    Get full text
    Article


  2. 2

    Case Report: Stevens-Johnson Syndrome and Hepatotoxicity Induced by Osimertinib Sequential to Pembrolizumab in a Patient With EGFR-Mutated Lung Adenocarcinoma by Caterina Gianni, Giuseppe Bronte, Angelo Delmonte, Marco Angelo Burgio, Kalliopi Andrikou, Manlio Monti, Cecilia Menna, Giovanni Luca Frassineti, Lucio Crinò

    Published in Frontiers in Pharmacology (2021-08-01)
    Get full text
    Article


  3. 3

    Preoperative CT Radiomics for Prognosis Prediction in Resected Early-Stage Non-Small Cell Lung Cancer by Elisabetta Petracci, Marie-Sophie von Braun, Andrea Iamurri Prochowski, Franco Stella, Beatrice Aramini, Matteo Canale, Milena Urbini, Angelo Delmonte, Martin Christian, Paola Ulivi

    Get full text
    Article


  4. 4

    Liquid Biopsy for EGFR Mutation Analysis in Advanced Non-Small-Cell Lung Cancer Patients: Thoughts Drawn from a Real-Life Experience by Paola Ulivi, Elisabetta Petracci, Matteo Canale, Ilaria Priano, Laura Capelli, Daniele Calistri, Elisa Chiadini, Paola Cravero, Alice Rossi, Angelo Delmonte, Lucio Crinò, Giuseppe Bronte

    Published in Biomedicines (2021-09-01)
    Get full text
    Article


  5. 5

    The Clinical Significance of Circulating Tumor DNA for Minimal Residual Disease Identification in Early-Stage Non-Small Cell Lung Cancer by Alberto Verlicchi, Matteo Canale, Elisa Chiadini, Paola Cravero, Milena Urbini, Kalliopi Andrikou, Luigi Pasini, Michele Flospergher, Marco Angelo Burgio, Lucio Crinò, Paola Ulivi, Angelo Delmonte

    Published in Life (2023-09-01)
    Get full text
    Article


  6. 6

    Prognosis of ALK-rearranged non-small-cell lung cancer patients carrying TP53 mutations by Matteo Canale, Elisabetta Petracci, Paola Cravero, Marita Mariotti, Gabriele Minuti, Giulio Metro, Vienna Ludovini, Sara Baglivo, Maurizio Puccetti, Alessandra Dubini, Giovanni Martinelli, Angelo Delmonte, Lucio Crinò, Paola Ulivi

    Published in Translational Oncology (2022-09-01)
    Get full text
    Article


  7. 7

    Detection of <i>EGFR</i> Mutations in Plasma Cell-Free Tumor DNA of TKI-Treated Advanced-NSCLC Patients by Three Methodologies: Scorpion-ARMS, PNAClamp, and Digital PCR by Annamaria Siggillino, Paola Ulivi, Luigi Pasini, Maria Sole Reda, Elisa Chiadini, Francesca Romana Tofanetti, Sara Baglivo, Giulio Metro, Lucio Crinó, Angelo Delmonte, Vincenzo Minotti, Fausto Roila, Vienna Ludovini

    Published in Diagnostics (2020-12-01)
    Get full text
    Article


  8. 8

    The Interplay Between Programmed Death Ligand 1 and Vimentin in Advanced Non-Small-Cell Lung Cancer by Giuseppe Bronte, Maurizio Puccetti, Elisabetta Petracci, Lorenza Landi, Paola Cravero, Simona Scodes, Paola Ulivi, Sara Ravaioli, Maria Maddalena Tumedei, Marco Angelo Burgio, Federico Cappuzzo, Angelo Delmonte, Lucio Crinò, Sara Bravaccini

    Published in Frontiers in Oncology (2021-05-01)
    Get full text
    Article


  9. 9

    Clinical implications of the family history in patients with lung cancer: a systematic review of the literature and a new cross-sectional/prospective study design (FAHIC: lung) by Fabrizio Citarella, Kazuki Takada, Priscilla Cascetta, Pierfilippo Crucitti, Roberta Petti, Bruno Vincenzi, Giuseppe Tonini, Francesco M. Venanzi, Alessandra Bulotta, Sara Oresti, Carlo Greco, Sara Ramella, Lucio Crinò, Angelo Delmonte, Roberto Ferrara, Massimo Di Maio, Fiorella Gurrieri, Alessio Cortellini

    Published in Journal of Translational Medicine (2024-07-01)
    Get full text
    Article


  10. 10

    Circulating cell-free and extracellular vesicles-derived microRNA as prognostic biomarkers in patients with early-stage NSCLC: results from RESTING study by Elisabetta Petracci, Luigi Pasini, Milena Urbini, Enriqueta Felip, Franco Stella, Fabio Davoli, Maurizio Salvi, Michele Beau-Faller, Michela Tebaldi, Irene Azzali, Matteo Canale, Piergiorgio Solli, Giulia Lai, Ramon Amat, Caterina Carbonell, Pierre-Emmanuel Falcoz, Alex Martinez-Marti, Erwan Pencreach, Angelo Delmonte, Lucio Crinò, Paola Ulivi

    Get full text
    Article


  11. 11

    Rare Driver Mutations in Advanced, Oncogene-Addicted Non-Small Cell Lung Cancer: A North Italian, Real-World, Registry Experience by Kalliopi Andrikou, Paola Ulivi, Elisabetta Petracci, Irene Azzali, Federica Bertolini, Giulia Alberti, Stefania Bettelli, Daniele Calistri, Elisa Chiadini, Laura Capelli, Paola Cravero, Giorgia Guaitoli, Francesca Zanelli, Marco Angelo Burgio, Maria Pagano, Alberto Verlicchi, Enrica Martinelli, Katia Di Emidio, Massimo Dominici, Carmine Pinto, Angelo Delmonte

    Published in Diagnostics (2024-05-01)
    Get full text
    Article


  12. 12

    Bridging therapeutic opportunities: a survey by the Italian molecular tumor board workgroup of Alliance Against Cancer by Gennaro Ciliberto, Marco Canfora, Irene Terrenato, Chiara Agnoletto, Francesco Agustoni, Loredana Amoroso, Gustavo Baldassarre, Giuseppe Curigliano, Angelo Delmonte, Antonella De Luca, Michelangelo Fiorentino, Vanesa Gregorc, Toni Ibrahim, Chiara Lazzari, Angela Mastronuzzi, Paolo Pronzato, Armando Santoro, Giovanni Scambia, Stefania Tommasi, Andrea Vingiani, Patrizio Giacomini, Ruggero De Maria

    Get full text
    Article


  13. 13

    Non-small cell lung cancer and the tumor microenvironment: making headway from targeted therapies to advanced immunotherapy by Anna De Lucia, Lucia Mazzotti, Lucia Mazzotti, Anna Gaimari, Anna Gaimari, Matteo Zurlo, Roberta Maltoni, Claudio Cerchione, Sara Bravaccini, Angelo Delmonte, Lucio Crinò, Patricia Borges de Souza, Luigi Pasini, Fabio Nicolini, Fabrizio Bianchi, Manel Juan, Hugo Calderon, Chiara Magnoni, Chiara Magnoni, Luca Gazzola, Luca Gazzola, Paola Ulivi, Massimiliano Mazza

    Published in Frontiers in Immunology (2025-02-01)
    Get full text
    Article


  14. 14

    Immunotherapy of mesothelioma: the evolving change of a long-standing therapeutic dream by Luana Calabrò, Luana Calabrò, Giuseppe Bronte, Giuseppe Bronte, Federica Grosso, Luigi Cerbone, Angelo Delmonte, Fabio Nicolini, Massimiliano Mazza, Anna Maria Di Giacomo, Anna Maria Di Giacomo, Alessia Covre, Alessia Covre, Alessia Covre, Maria Fortunata Lofiego, Maria Fortunata Lofiego, Maria Fortunata Lofiego, Lucio Crinò, Michele Maio, Michele Maio, Michele Maio, Michele Maio

    Published in Frontiers in Immunology (2024-01-01)
    Get full text
    Article


  15. 15

    KRAS G12 isoforms exert influence over up-front treatments: A retrospective, multicenter, Italian analysis of the impact of first-line immune checkpoint inhibitors in an NSCLC real... by Sara Fancelli, Sara Fancelli, Enrico Caliman, Enrico Caliman, Francesca Mazzoni, Luca Paglialunga, Marta Rita Gatta Michelet, Daniele Lavacchi, Rossana Berardi, Giulia Mentrasti, Giulio Metro, Ilaria Birocchi, Angelo Delmonte, Ilaria Priano, Camilla Eva Comin, Camilla Eva Comin, Francesca Castiglione, Caterina Bartoli, Luca Voltolini, Luca Voltolini, Serena Pillozzi, Lorenzo Antonuzzo, Lorenzo Antonuzzo, Lorenzo Antonuzzo

    Published in Frontiers in Oncology (2022-11-01)
    Get full text
    Article


  16. 16

    A real-world retrospective, observational study of first-line pembrolizumab plus chemotherapy for metastatic non-squamous non-small cell lung cancer with PD-L1 tumor proportion sco... by Alessandro Cafaro, Flavia Foca, Oriana Nanni, Marco Chiumente, Marina Coppola, Paolo Baldo, Sabrina Orzetti, Fiorenza Enrico, Vito Ladisa, Rosa Lerose, Patrizia Nardulli, Piera Maiolino, Federica Gradellini, Anna Rita Gasbarro, Gisella Carrucciu, Riccardo Provasi, Paola Cristina Cappelletto, Alessandra Pasqualini, Stefano Vecchia, Marianna Veraldi, Adele Emanuela De Francesco, Lucio Crinò, Angelo Delmonte, Carla Masini

    Published in Frontiers in Oncology (2024-03-01)
    Get full text
    Article


  17. 17

    607 TTFields therapy with an immune checkpoint inhibitor in metastatic non-small cell lung cancer (mNSCLC) with progression on/after platinum-based therapy: histology subgroups in... by Li Zhang, Goetz Kloecker, Christian Rolfo, Wallace Akerley, Miklos Pless, Lubos Petruzelka, Zoran Andric, Joachim Aerts, Libor Havel, Jeffrey Ward, Richard Greil, David E Gerber, Janusz Milanowski, Angelo Delmonte, Sujith Kalmadi, Rodryg Ramlau, Rupesh Kotecha, Corey Langer, Ticiana A Leal, Manuel Cobo Dols, Jaromír Roubec, Thierry Berghmans, Rajiv Panikkar, Michael Eaton, Mussawar Iqbal

    Published in Journal for ImmunoTherapy of Cancer (2023-11-01)
    Article


Search Tools: